HebeCell and Logomix form a strategic partnership to develop gene-edited NK cells and genetic modifications to create next gen designer NK cells.
Our President and CEO John Lu was recently interviewed by IMAPAC on key developments, technologies and challenges in Asia's Cell and Gene Therapy Industry. You can find the full interview in the PDF attached.